Vasomotor symptoms (VMS) presence or severity was not associated with levels of hemostatic parameters, a recent study found. The cross-sectional analysis included 2,148 postmenopausal women with measures of VMS presence and severity reported in the 4 weeks before Women’s Health Initiative (WHI) baseline, and not using warfarin or hormone therapy. Researchers found:
- Women were aged 67 years on average and 33% reported VMS presence at baseline.
- VMS presence may be associated with a -0.34 adjusted difference in normalized activated protein C sensitivity ratio compared with no VMS, but this association was not significant.
- VMS presence or severity was not significantly associated with the other hemostatic parameters.
Harrington LB, Blondon M, Cushman M, et al. The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women. [Published online ahead of print December 5, 2016]. Menopause. doi:10.1097/GME.0000000000000777.
This Week's Must Reads
Must Reads in Menopause
Menopause Symptom Burden and Chronic Pain, Menopause; ePub 2019 Mar 4; Gibson, et al
Trends in Menopausal Hormone Therapy, Menopause; ePub 2018 Dec 21; Crawford, et al
Chronic Disease Risk with Vaginal Estrogen Use, Menopause; ePub 2018 Dec 17; Bhupathiraju, et al
Sleep Disturbance After Surgical Menopause, Menopause; ePub 2018 Nov 12; Cho, Kim, et al
Cardiac Autonomic Function in Midlife Women, Menopause; ePub 2018 Jun 18; Fu, et al